Flow cytometry for drug discovery, receptor pharmacology and high-throughput screening

Current Opinion in Pharmacology

Volumn 7, Issue 5, 2007, Pages 527-534

  Sklar, Larry A ^a   Carter, Mark B ^a   Edwards, Bruce S ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILEUKEMIC AGENT; DIHYDROALPRENOLOL; ENZASTAURIN; HYBRID PROTEIN; PHOSPHOPROTEIN; PROTEIN KINASE C; T LYMPHOCYTE RECEPTOR;

APOPTOSIS; AUTOMATION; BINDING AFFINITY; CATALYSIS; CD4+ T LYMPHOCYTE; CELL ASSAY; CELL SELECTION; CELLULAR IMMUNITY; CYTOTOXICITY; DRUG RESEARCH; DRUG SCREENING; ENZYME ACTIVITY; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; HIGH THROUGHPUT SCREENING; HUMAN; IMAGE DISPLAY; IMAGE QUALITY; LIGAND BINDING; NONHUMAN; PARTICLE SIZE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DETERMINATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; REVIEW; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; VACCINE PRODUCTION;

ANIMALS; DRUG DESIGN; FLOW CYTOMETRY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; NATIONAL INSTITUTES OF HEALTH (U.S.); PARTICLE SIZE; PHOSPHOPROTEINS; UNITED STATES;

EID: 35248879157     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2007.06.006     Document Type: Review

References (51)

1. In: Sklar L.A. (Ed). Flow Cytometry for Biotechnology (2005), Oxford University Press
2. Herzenberg L.A., Parks D., Sahaf B., Perez O., Roederer M., and Herzenberg L.A. The history and future of the fluorescence activated cell sorter and flow cytometry: a view from Stanford. Clin Chem 48 (2002) 1819-1827
3. Bonetta L. Flow cytometry, smaller and better. Nat Meth 2 10 (2005) 785-795
4. Robinson J.P. Flow cytometry. In: Wnek G.E., and Bowlin G.L. (Eds). Encyclopedia of Biomaterials and Biomedical Engineering (2004), Marcel Dekker Inc. 630-640
5. Paul Robinson J (Managing Editor): Current Protocols in Cytometry, Wiley Interscience, http://www.currentprotocols.com/WileyCDA/CPTitle/isbn-0471161314.html.
6. Nolan J.P., Lauer S., Prossnitz E.R., and Sklar L.A. Flow cytometry: a versatile tool for all phases of Drug Discovery. Drug Discov Today 4 (1998) 173-180
7. Shapiro, and Howard M. Fluorescent probes. In: Sklar L.A. (Ed). Flow Cytometry for Biotechnology (2005), Oxford University Press 15-39
8. Green L.J., Marder P., Ray C., Cook C.A., Jaken S., Musib L.C., Herbst R.S., Carducci M., Britten C.D., Basche M., et al. Development and validation of a drug activity biomarker that shows target inhibition in cancer patients receiving enzastaurin, a novel protein kinase C-beta inhibitor. Clin Cancer Res 12 (2006) 3408-3415
9. Nolan J.P., and Sklar L.A. The emergence of flow cytometry for the sensitive, real-time analysis of molecular assembly. Nat Biotechnol 16 (1998) 833-838
10. Sklar L.A., Edwards B.S., Graves S., Nolan J.P., and Prossnitz E.R. Flow cytometry for analysis of membrane ligand-receptor interactions and macromolecular assembly. Ann Rev Biophys 31 (2002) 97-119
11. Nolan J.P., and Sklar L.A. Suspension array technology: evolution of the flat array paradigm. TIBS 20 (2002) 9-12
12. Kellar K.L., and Iannone A. Muliplex microsphere-based flow cytometric assays. Exp Hematol 30 11 (2002) 1227-1237
13. Nolan J.P., and Francis M.J. Multiplexed and microparticle-based analyses: quantitative tools for the large-scale analysis of biological systems. Cytometry: Part A 69 5 (2006) 318-325
14. Roman D., Talbot J.N., Roof R.A., Sunahara R.K., Traynor J.R., and Neubig R.R. Identification of small molecule inhibitors of regulator of G-protein signaling 4 (RGS4) using a high throughput flow cytometry protein interaction assay (FCPIA). Mol Pharmacol 71 1 (2006) 169-175
15. Saunders M.J., Kim H., Woods T.A., Nolan J.P., Sklar L.A., Edwards B.S., and Graves S.W. Microsphere based protease assays and screening application for lethal factor and factor Xa. Cytometry A 69 (2006) 342-352
16. Simons P., Shi M., Foutz T., Lewis J., Buranda T., Lim W.K., Neubig R., Garrison J., Prossnitz E.R., and Sklar L.A. Beads coated with epitope tagged G proteins assemble complexes of ligand-receptor-G protein for detection by flow cytometry. Mol Pharm 64 (2003) 1227-1238
17. Simons S., Biggs S., Waller A., Foutz T., Cimino D.F., Guo Q., Neubig R.R., Tang W.-J., Prossnitz E.R., and Sklar L.A. Direct evidence for partial agonist activity at the antagonist-receptor-G protein complex step of signal transduction. JBC 279 (2004) 13514-13521
18. Waller A., Simons P.C., Biggs M., Edwards B.S., Prossnitz E.R., and Sklar L.A. GPCR pharmacology and screening by flow cytometry. Trends Pharmacol 25 12 (2004) 663-669
19. Krutzik P.O., and Nolan G.P. Fluorescent cell barcoding in flow cytometry allows high throughput drug screening and signaling profiling. Nat Meth 3 5 (2006) 361-368
20. Basiji D. Multispectral imaging in flow. In: Sklar L.A. (Ed). Flow Cytometry for Biotechnology (2005), Oxford University Press 57-67
21. Lang P., Yeow K., Nichols A., and Scheer A. Cellular imaging in Drug Discovery. Nat Rev Drug Discov 5 (2006) 343-356
22. Schneider E., Mayer M., Ziemek R., Li L., Hutzler C., Bernhardt G., and Buschauer A. A simple and powerful flow cytometric method for the simultaneous determination of multiple parameters at G protein-coupled receptor subtypes. Chembiochem 7 9 (2006) 1400-1409
23. Perfetto S.P., Chattopadhay P.K., and Roederer M. Seventeen-colour flow cytometry: unravelling the immune system. Nat Rev Immunol 4 8 (2004) 648-655
24. Chattopadhyay P.K., Price D.A., Harper T.F., Betts M.R., Yu J., Gostick E., Perfetto S.P., Goepfert P., Koup R.A., De Rosa S.C., et al. Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry. Nat Med 12 8 (2006) 972-977
25. Roederer M., and De Rosa S.C. Multiparameter analysis: application to vaccine analysis. In: Sklar L.A. (Ed). Flow Cytometry for Biotechnology (2005), Oxford University Press 181-192
26. Chow S.P., and Hedley D.W. Measurement of MAP kinase activation by flow cytometry using phospho-specific antibodies to MEK and ERK: potential for pharmacodynamic monitoring of signal transduction inhibitors. Cytometry 46 2 (2001) 72-78
27. Krutzik P., and Nolan G.P. Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events. Cytometry Part A 55 2 (2003) 61-70
28. Irish J.H., Krutzik P.O., Perez O.D., Bruserud O., Gjertsen B.T., and Nolan G.P. Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell 118 2 (2004) 217-228
29. Butcher E.C. Can cell systems biology rescue drug discovery?. Nat Rev Drug Discov 4 (2005) 461-467
30. Sachs K., Perez O., Pe'er D., Lauffenburger D.A., and Nolan G.P. Causal protein-signaling networks derived from multiparameter single-cell data. Science 308 (2005) 523-529
31. Ortyn W.E., Hall B.E., George T.C., Frost K., Basiji D.A., Perry D.J., Zimmerman C.A., Coder D., and Morrissey P.J. Sensitivity measurement and compensation in spectral imaging. Cytometry Part A 69A (2006) 852-862
32. George T.C., Fanning S.L., Fitzgerald-Bocarsly P., Medeiros R.B., Highfill S., Shimizu Y., Hall B.E., Frost K., Basiji D.A., Ortyn W.E., et al. Quantitative measurement of nuclear translocation events using similarity analysis of multispectral cellular images obtained in flow. J Immunol Meth 311 1-2 (2006) 117-129
33. George T.C., Basiji D.A., Hall B.E., Lynch D.H., Ortyn W.E., Perry D.J., Seo M.J., Zimmerman C.A., and Morrissey P.J. Distinguishing modes of cell death using the ImageStream Multispectral Imaging Spectrometer. Cytometry 59A (2004) 237-245
34. Becker S., Schmoldt H.U., Adams T.M., Wilhelm S., and Kolmar H. Ultra-high-throughput screening based on cell-surface display and fluorescence-activated cell sorting for the identification of novel biocatalysts. Curr Opin Biotechnol 4 (2004) 323-329
35. Olsen M.J., Gam J., Iverson B.L., and Georgiou G. High-throughput FACS method for directed evolution of substrate specificity. Meth Mol Biol 230 (2003) 329-342
36. Aharoni A., Thieme K., Chiu C.P., Buchini S., Lairson L.L., Chen H., Strynadka N.C., Wakarchuk W.W., and Withers S.G. High throughput screening methodology for the directed evolution of glycolsyltransferase. Nat Meth 3 8 (2006) 609-614
37. Farinas E.T. Fluorescence activated cell sorting for enzymatic activity. Comb Chem High Throughput Screen 9 4 (2006) 321-328
38. Pali E., Powell M., Masuda E., Hitoshi Y., Holland S., Bennett M.K., Molineaux S.M., Payan D.G., and Lorens J.B. FACS-based high-throughput functional screening of genetic libraries for drug target discovery. In: Sklar L.A. (Ed). Flow Cytometry for Biotechnology (2005), Oxford University Press 193-211
39. Lorens J.B., Pearsall D.M., Swift S.E., Peelle B., Armstrong R., Demo S.D., Ferrick D.A., Hitoshi Y., Payan D.G., and Anderson D. Stable, stoichiometric delivery of diverse protein functions. J Biochem Biophys Meth 58 2 (2004) 101-110
40. Kumaresan P.R., and Lam K.S. Screening chemical microarrays: methods and applications. Mol Biosyst 2 5 (2006) 259-270
41. Peng L., Liu R., Marik J., Wang X., Takada Y., and Lam K.S. Combinatorial chemistry identifies high-affinity peptidomimetics against alpha4beta1 integrin for in vivo tumor imaging. Nat Chem Biol 2 7 (2006) 351-352
42. da Silva T.L., Reis A., Kent C.A., Roseiro J.C., and Hewitt C.J. The use of multi-parameter flow cytometry to study the impact of limiting substrate, agitation intensity, and dilution rate on cell aggregation during Bacillus licheniformis CCMI 1034 aerobic continuous culture fermentations. Biotechnol Bioeng 92 5 (2005) 568-578
43. Kacmar J., and Srienc F. Dynamics of single cell property distributions in Chinese hamster ovary cell cultures monitored and controlled with automated flow cytometry. J Biotechnol 120 4 (2005) 410-420
44. Larson R.S., Chigaev A., Edwards B.S., Ramirez S.A., Winter S.S., Zwartz G., and Sklar L.A. Applications of flow cytometry to the biology of cell adhesion: from aggregates to drug design. In: Sklar L.A. (Ed). Flow Cytometry for Biotechnology (2005), Oxford University Press 347-374
45. Zwartz G.J., Chigaev A., Dwyer D., Foutz T.D., Edwards B.S., and Sklar L.A. Real-time analysis of VLA-4 affinity modulation by shear. JBC 276 (2004) 32435-32443
46. Edwards B.S., Kuckuck F.W., Prossnitz E.R., Ransom J.T., and Sklar L.A. HTPS flow cytometry: a novel platform for automated high throughput drug discovery and characterization. J Biomol Screen 6 (2001) 83-90
47. Edwards B.S., Oprea T., Prossnitz E.R., and Sklar L.A. Flow cytometry for high-throughput, high-content screening. Curr Opin Chem Biol 8 (2004) 392-398
48. Young S.M., Bologa C., Prossnitz E.R., Oprea T.I., Sklar L.A., and Edwards B.S. High-throughput screening with HyperCyt flow cytometry to detect small molecule formylpeptide receptor ligands. J Biomol Screen 10 (2005) 374-382
49. Edwards B.S., Bologa C., Young S.M., Balakin K.V., Prossnitz E.R., Savchuck N.P., Sklar L.A., and Oprea T.I. Integration of virtual screening with high throughput flow cytometry to identify novel small molecule formylpeptide receptor antagonists. Mol Pharmacol 68 5 (2005) 1301-1310
50. Revankar C., Cimino D., Sklar L.A., Arterburn J., and Prossnitz E.R. An intracellular 7-transmembrane G-protein coupled estrogen receptor mediates rapid cell signaling. Science 307 (2005) 1625-1630
51. Bologa C.G., Revankar C.M., Young S.M., Edwards B.S., Arterburn J.B., Kiselyov A.S., Parker M.A., Tkachenko S.E., Savchuck N.P., Sklar L.A., et al. Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat Chem Biol 4 (2006) 207-212